EFFICACY OF KARXT ON NEGATIVE SYMPTOMS IN ACUTE SCHIZOPHRENIA: AN ANALYSIS OF POOLED DATA FROM 3 TRIALS

被引：0
|
作者：
Vuocolo, Scott [1 ]
Horan, William P. [1 ]
Claxton, Amy [1 ]
Targum, Steven D. [2 ]
Kaul, Inder [1 ]
Sawchak, Sharon [1 ]
Miller, Andrew C. [1 ]
Paul, Steven M. [1 ]
Brannan, Stephen K. [1 ]
机构：
[1] Karuna Therapeut, Boston, MA USA
[2] Signant Hlth, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2025年 / 28卷
关键词：
KarXT; muscarinic receptors; negative symptoms; schizophrenia; xanomeline;
D O I：
10.1093/ijnp/pyae059.636
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
pyae059.63
引用
收藏
页码：358 / 359
页数：2
相关论文
共 50 条
  • [21] Does short-term antipsychotic discontinuation of up to 3 weeks worsen symptoms in acute schizophrenia? A pooled analysis of placebo washout data
    Takeuchi, Hiroyoshi
    Watabe, Kei
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2023, 77 (06) : 338 - 344
  • [22] The efficacy of amisulpride on negative symptoms in chronic schizophrenia
    Vasile, D
    Gheorghe, MD
    Vasiliu, O
    Paraschiv, SL
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S410 - S410
  • [23] Efficacy of Telcagepant in Subgroups: Pooled Analysis of Data from Phase 3 Studies
    Ho, T. W.
    Connor, K. M.
    Ho, A. P.
    Kost, J. T.
    Fan, X.
    Dodick, D. W.
    Silberstein, S. D.
    Lines, C. R.
    Assaid, C.
    HEADACHE, 2010, 50 : S16 - S16
  • [24] Efficacy of telcagepant in subgroups: pooled analysis of data from phase 3 studies
    Ho, T. W.
    Connor, K. M.
    Ho, A. P.
    Kost, J. T.
    Fan, X.
    Dodick, D. W.
    Silberstein, S. D.
    Lines, C. R.
    Assaid, C.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S40 - S41
  • [25] Efficacy of telcagepant in subgroups: pooled analysis of data from phase 3 studies
    Ho, T. W.
    Connor, K. M.
    Ho, A. P.
    Kost, J. T.
    Fan, X.
    Dodick, D. W.
    Silberstein, S. D.
    Lines, C. R.
    Assaid, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 245 - 245
  • [26] Efficacy of Lurasidone in the Treatment of Schizophrenia with Prominent Negative Symptoms: A Post-hoc Analysis of Short-term Trials
    Schooler, Nina R.
    Pikalov, Andrei
    Hsu, Jay
    Cucchiaro, Josephine
    Goldman, Robert
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S513 - S514
  • [27] Efficacy of Second-Generation-Antipsychotics in the treatment of negative symptoms of schizophrenia: A meta-analysis of randomized clinical trials
    Darba, Josep
    Minoves, Agnes
    Rojo, Emilio
    Jimenez, Francesca
    Rejas, Javier
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2011, 4 (03): : 126 - 143
  • [28] EFFICACY OF LURASIDONE IN THE TREATMENT OF SCHIZOPHRENIA WITH PROMINENT NEGATIVE SYMPTOMS: A POST-HOC ANALYSIS OF SHORT-TERM TRIALS
    Pikalov, Andrei
    Schooler, Nina
    Hsu, Jay
    Cucchiaro, Josephine
    Goldman, Robert
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S355 - S355
  • [29] Efficacy of Telcagepant in Subgroups: Pooled Analysis of Data from Phase 3 Studies
    Ho, Tony W.
    Connor, Kathryn M.
    Ho, Andrew P.
    Kost, James T.
    Fan, Xiaoyin
    Dodick, David W.
    Silberstein, Stephen D.
    Lines, Christopher R.
    Assaid, Christopher
    NEUROLOGY, 2010, 74 (09) : A396 - A397
  • [30] Efficacy of lurasidone in the treatment of schizophrenia with prominent negative symptoms: A post-hoc analysis of short-term trials
    Schooler, N. R.
    Pikalov, A.
    Hsu, J.
    Cucchiaro, J.
    Goldman, R.
    Loebel, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 151 - 152
12345